World's Best Scientists 2026 revealed!
Laurent Meijer

Laurent Meijer

Award Badge
Biology and Biochemistry
France
2023

D-Index & Metrics

Biology and Biochemistry

D-Index
103
Citations
46382
World Ranking
1298
National Ranking
25

Laurent Meijer publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Laurent Meijer sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 397 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Laurent Meijer D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Laurent Meijer sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 103 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in France Leader Award

Overview

Laurent Meijer is affiliated with Perha Pharmaceuticals in France and has contributed extensively to biomedical research, particularly in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans 35 publications in Medicine and 29 in Biochemistry, Genetics and Molecular Biology, reflecting a strong focus on molecular and genetic mechanisms relevant to human health.

The scientist's research interests are notably centered on molecular biology, organic chemistry, neurology, public health, genetics, and their intersections. Specific subfields of study include:

  • Molecular Biology
  • Organic Chemistry
  • Neurology
  • Public Health, Environmental and Occupational Health
  • Genetics

Laurent Meijer has contributed to main research topics such as:

  • Down syndrome and intellectual disability research
  • Alzheimer's disease research and treatments
  • Neuroblastoma Research and Treatments
  • Cancer, Hypoxia, and Metabolism
  • Cell death mechanisms and regulation
  • Cystic Fibrosis Research Advances
  • Metabolism, Diabetes, and Cancer

Their recent scientific publications cover key developments in kinase inhibitors, genetic dosage effects, and neurodegenerative pathology treatments. Notable recent papers include:

  • "Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview" (2021) published in International Journal of Molecular Sciences
  • "Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases" (2023) published in Journal of Medicinal Chemistry
  • "Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome" (2024) published in Science Translational Medicine
  • "A Small Compound Targeting Prohibitin with Potential Interest for Cognitive Deficit Rescue in Aging mice and Tau Pathology Treatment" (2020) published in Scientific Reports
  • "Leucettinibs, a Class of DYRK/CLK Kinase Inhibitors Inspired by the Marine Sponge Natural Product Leucettamine B" (2023) published in Journal of Medicinal Chemistry

Laurent Meijer's publications have appeared frequently in the following scientific journals:

  • Journal of Medicinal Chemistry
  • Scientific Reports
  • bioRxiv (Cold Spring Harbor Laboratory)
  • International Journal of Molecular Sciences
  • Pharmaceuticals

The scientist collaborates regularly with several researchers, including:

  • Mattias F. Lindberg
  • Emmanuel Deau
  • Yann Hérault
  • Priyanka Gupta
  • Keehn Strange

Laurent Meijer's body of work is characterized by a multidisciplinary approach addressing complex biomedical issues such as intellectual disabilities, neurodegenerative diseases, and cancer metabolism. Their research integrates molecular biology with therapeutic development, contributing to understanding the biochemical basis of human disease and potential treatment strategies.

Best Publications

  • Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor

    Noboru Sato;Laurent Meijer;Laurent Meijer;Leandros Skaltsounis;Paul Greengard

  • Biochemical and Cellular Effects of Roscovitine, a Potent and Selective Inhibitor of the Cyclin‐Dependent Kinases cdc2, cdk2 and cdk5

    Laurent Meijer;Annie Borgne;Odile Mulner;James P.J. Chong

  • Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis

    Laurent Meijer;Deborah J Nelson;Vladimir Riazanski;Aida G Gabdoulkhakova

  • Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.

    Nathanael S. Gray;Lisa Wodicka;Andy-Mark W. H. Thunnissen;Thea C. Norman

  • Indirubins Inhibit Glycogen Synthase Kinase-3β and CDK5/P25, Two Protein Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer's Disease A PROPERTY COMMON TO MOST CYCLIN-DEPENDENT KINASE INHIBITORS?

    Sophie Leclerc;Matthieu Garnier;Ralph Hoessel;Doris Marko

  • Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.

    Ralph Hoessel;Sophie Leclerc;Jane A. Endicott;Martin E. M. Nobel

  • GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins

    Laurent Meijer;Alexios-Leandros Skaltsounis;Prokopios Magiatis;Panagiotis Polychronopoulos

  • Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine.

    W.F. De Azevedo;S. Leclerc;L. Meijer;L. Havlicek

  • Inhibition of Cyclin‐Dependent Kinases by Purine Analogues

    Walter Filgueira De Azevedo;Sophie Leclerc;Laurent Meijer;Libor Havlicek

  • Pharmacological inhibitors of glycogen synthase kinase 3

    Laurent Meijer;Marc Flajolet;Paul Greengard

  • Pharmacological inhibitors of cyclin-dependent kinases

    Marie Knockaert;Paul Greengard;Laurent Meijer

  • Constitutive Phosphorylation of the Parkinson's Disease Associated α-Synuclein *

    Masayasu Okochi;Jochen Walter;Akihiko Koyama;Shigeo Nakajo

  • cdc2 is a component of the M phase-specific histone H1 kinase: Evidence for identity with MPF

    Dominique Arion;Laurent Meijer;Leonardo Brizuela;David Beach

  • Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons

    James A. Bibb;Gretchen L. Snyder;Akinori Nishi;Zhen Yan

  • Inhibition of cyclin-dependent kinases, GSK-3β and CK1 by hymenialdisine, a marine sponge constituent

    L. Meijer;A. M W H Thunnissen;A. W. White;M. Garnier

  • Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases.

    Panagiotis Polychronopoulos;Prokopios Magiatis;Alexios-Leandros Skaltsounis;Vassilios Myrianthopoulos

  • Paullones are potent inhibitors of glycogen synthase kinase‐3β and cyclin‐dependent kinase 5/p25

    Maryse Leost;Christiane Schultz;Andreas Link;Yong Zhong Wu

  • Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials.

    Laurent Meijer;Eric Raymond

  • Synthesis, anti-inflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/benzoxazole derivatives and some Schiff’s bases

    Sham M Sondhi;Nirupma Singh;Ashok Kumar;Olivier Lozach

  • Roscovitine Targets, Protein Kinases and Pyridoxal Kinase

    Stéphane Bach;Marie Knockaert;Jens Reinhardt;Olivier Lozach

Frequent Co-Authors

Thierry Besson
Thierry Besson University of Rouen
Christian Doerig
Christian Doerig RMIT University
Prokopios Magiatis
Prokopios Magiatis National and Kapodistrian University of Athens
Stefan Knapp
Stefan Knapp Goethe University Frankfurt
Nathanael S. Gray
Nathanael S. Gray Stanford University
Alexios-Leandros Skaltsounis
Alexios-Leandros Skaltsounis National and Kapodistrian University of Athens
Miroslav Strnad
Miroslav Strnad Palacký University, Olomouc
Paul Greengard
Paul Greengard Rockefeller University
Doris Marko
Doris Marko University of Vienna
Jane A. Endicott
Jane A. Endicott Newcastle University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Laurent Meijer

Trending Scientists

Recently Published Articles